International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia.
The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said.
Employing cognitive and neurobehavioral...
It’s no secret that digital is shaping what clinical trials will look like in the future. A recently published position paper published in Nature discusses the potentials and challenges of digital clinical trials. The paper builds on a workshop held by the U.S. National Institutes of Health and the National Science Foundation in April of 2019.
One of the big opportunities that the paper outlines...
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company.
WHAT IT DOES
Founded in 2013, the company's platform provides insights from RWE to decision-makers...
The Consumer Technology Association (CTA) announced this morning a new group of 24 technology and digital health companies aiming to develop industry-wide standards for digital therapeutics use.
Headlined by big names like Google Health, Doctor on Demand, HP, Livongo and ResMed (see below for the full list), the initiative is tackling the amorphous definitions and terminologies that abound within...
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
CREDIT: Bahrain News Agency
Bahrain’s National Health Regulatory Authority (NHRA) has announced plans to establish a track and trace electronic system to monitor the supply chain of medicines in the Kingdom. This new system will reportedly cover the entire process, from factory of origin to final patient.
The NHRA stated that the platform was to ensure that medicines – including controlled substances – are dispensed...
Picking through the scraps. Following the bankruptcy of 'digital pill' maker Proteus Digital Health, business partner and stakeholder Otsuka Pharmaceutical has been approved to purchase the digital health company's assets by a federal bankruptcy court judge, STAT reports.
Otsuka's bid was challenged by Novartis, two former Proteus executives and other investors, who argued that the agreed upon $...
A European consortium has been launched to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19.
Corona Accelerated R&D in Europe (CARE), is the largest undertaking of its kind dedicated to creating effective therapies with a positive safety profile and repurposing existing therapies for the pandemic.
It aims to boost R&...
The United States Postal Service has been at the heart of a bitter partisan divide over the last few months of COVID-19 and the U.S. election season.
Prominent Democratic politicians have alleged that recent reforms and administrative changes ushered by recently appointed Postmaster General Louis DeJoy have led to widespread service delays across the country. At the same time, President Donald...
GoodRx, an online pharmacy platform for low-cost prescriptions and price comparisons, has submitted the SEC forms necessary for an IPO, Reuters reports.
The timing of the startup's listing is still in the air, however, with 2020 and early 2021 both on the table depending on developments in the market, according to the anonymous source. GoodRx is still in the process of hiring advisors for the...
